# GATA3

## Overview
GATA3 is a gene that encodes the GATA binding protein 3, a zinc finger transcription factor that plays a pivotal role in various biological processes, including immune system function and cellular differentiation. The protein is characterized by its two zinc finger domains, which facilitate its binding to specific DNA sequences, thereby regulating gene expression. GATA3 is crucial for the differentiation of T helper 2 (TH2) cells and the regulation of TH2-type cytokines, which are essential for immune responses. Beyond the immune system, GATA3 is expressed in multiple tissues, such as the adrenal glands, kidneys, and central nervous system, where it influences cellular differentiation and development. In the context of cancer, particularly breast cancer, mutations in the GATA3 gene are associated with altered cellular signaling and tumor progression, highlighting its dual role as both a tumor suppressor and promoter depending on the mutation and context (Afzaljavan2021GATA3; Cohen2014Shift; Ho2009GATA3).

## Structure
GATA3 is a zinc finger transcription factor characterized by its two zinc finger domains, which are crucial for DNA binding. The primary structure of GATA3 consists of 444 amino acids, with specific regions dedicated to distinct functions. The DNA-binding domain is located between amino acids 303 and 348, while the trans-activation domain spans amino acids 30 to 74 (Yang1994Human). The zinc finger domains, ZnFn1 and ZnFn2, are essential for binding to the GATA consensus motif, with ZnFn1 having broader specificity (Ho2009GATA3).

The secondary structure includes alpha helices and beta sheets, which contribute to the protein's stability and function. The tertiary structure involves the overall 3D folding of the protein, which is crucial for its interaction with DNA and other proteins. Missense mutations in the zinc finger domains can lead to structural deformations and decreased stability, affecting the protein's function (Kumar2020Structural).

GATA3 also undergoes post-translational modifications, which modulate its activity and are important for its physiological functions (Qiang2023Gene). The protein's structure allows it to act as a pioneer factor, binding to nucleosomal DNA and facilitating chromatin remodeling (Qiang2023Gene).

## Function
GATA3 (GATA binding protein 3) is a transcription factor that plays a crucial role in the development and function of T cells, particularly in the differentiation of T helper 2 (TH2) cells. It is involved in the regulation of TH2-type cytokines, such as interleukin-4 (IL-4), IL-5, and IL-13, which are essential for TH2-cell differentiation and immune responses (Ho2009GATA3). GATA3 operates through both STAT6-dependent and STAT6-independent pathways, with the latter involving Notch signaling, which can initiate TH2-cell differentiation (Ho2009GATA3).

In addition to its role in the immune system, GATA3 is expressed in various tissues, including the adrenal glands, kidneys, and central nervous system, where it contributes to cellular differentiation and development (Ho2009GATA3). In the skin, GATA3 inhibits keratinocyte proliferation and promotes differentiation, maintaining epidermal homeostasis (Masse2013GATA3). It is also essential for the differentiation and maintenance of luminal epithelial cells in the mammary gland, where it regulates cell cycle and differentiation processes (Chou2009GATA3). GATA3's activity is primarily nuclear, where it binds to specific DNA sequences to modulate gene expression (Ho2009GATA3).

## Clinical Significance
Mutations and altered expression of the GATA3 gene are significantly associated with breast cancer. In luminal breast cancer, GATA3 mutations are common and can lead to distinct molecular signatures and clinical phenotypes. These mutations often occur in the DNA-binding domain, affecting the gene's regulatory functions and contributing to cancer progression by altering hormone and growth factor signaling, increasing proliferation, and decreasing apoptosis (Cohen2014Shift). Specific mutations, such as frameshift mutations, can result in truncated proteins that may act in a dominant negative manner, impacting disease-free survival and drug sensitivity (Mair2016Gain).

GATA3 mutations are also linked to resistance to endocrine therapy in hormone receptor-positive breast cancer, despite being associated with a generally favorable prognosis (Afzaljavan2021GATA3). In addition, certain GATA3 mutations, like GATA3 335fs, promote abnormal mammary gland development and confer a growth advantage in both normal and malignant mammary cells, suggesting a role in tumor progression (EMMANUEL2018Mutant). These findings highlight the complex role of GATA3 in breast cancer, where it can function as both a tumor suppressor and a promoter, depending on the context and specific mutations involved.

## Interactions
GATA3 interacts with various proteins and nucleic acids, playing a significant role in different biological processes. In cancer, GATA3 interacts with hypoxia-inducible factor 1-alpha (HIF-1α), stabilizing it and enhancing cancer cell invasiveness. This interaction is crucial for the regulation of HIF-1 target genes, such as PGK1, CA9, SLC2A1, SLC2A3, and VEGFA, particularly under hypoxic conditions. The interaction is specific to the N-terminal part of HIF-1α, which includes the basic helix-loop-helix and Per-ARNT-Sim domains (Lin2017GATA3).

GATA3 also interacts with the transcription factors Sp1 and AP4 to regulate the transcriptional activity of the dopamine β-hydroxylase (DBH) gene. GATA3 binds to specific sites on the DBH promoter, and its interaction with Sp1 is essential for transactivation. The minimal domain of GATA3 required for interaction with Sp1 includes amino acid residues 268-364 (Hong2008Transcription).

In the context of Th2 cell differentiation, GATA3 interacts with Bcl11b, forming a transcriptional repressive complex. Bcl11b acts as a negative regulator of GATA3-mediated gene regulation, influencing Th2 cytokine production and cell differentiation (Fang2018Bcl11b).


## References


[1. (Hong2008Transcription) Seok Jong Hong, Hyun Jin Choi, Sunghoi Hong, Youngbuhm Huh, Han Chae, and Kwang-Soo Kim. Transcription factor gata-3 regulates the transcriptional activity of dopamine β-hydroxylase by interacting with sp1 and ap4. Neurochemical Research, 33(9):1821–1831, March 2008. URL: http://dx.doi.org/10.1007/s11064-008-9639-3, doi:10.1007/s11064-008-9639-3. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11064-008-9639-3)

[2. (Qiang2023Gene) Zekai Qiang, Ibrahim Jubber, Kirsty Lloyd, Marcus Cumberbatch, and Jon Griffin. Gene of the month: gata3. Journal of Clinical Pathology, 76(12):793–797, September 2023. URL: http://dx.doi.org/10.1136/jcp-2023-209017, doi:10.1136/jcp-2023-209017. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1136/jcp-2023-209017)

[3. (Mair2016Gain) Barbara Mair, Tomasz Konopka, Claudia Kerzendorfer, Katia Sleiman, Sejla Salic, Violeta Serra, Markus K. Muellner, Vasiliki Theodorou, and Sebastian M. B. Nijman. Gain- and loss-of-function mutations in the breast cancer gene gata3 result in differential drug sensitivity. PLOS Genetics, 12(9):e1006279, September 2016. URL: http://dx.doi.org/10.1371/journal.pgen.1006279, doi:10.1371/journal.pgen.1006279. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1006279)

[4. (Chou2009GATA3) Jonathan Chou, Sylvain Provot, and Zena Werb. Gata3 in development and cancer differentiation: cells gata have it! Journal of Cellular Physiology, 222(1):42–49, October 2009. URL: http://dx.doi.org/10.1002/jcp.21943, doi:10.1002/jcp.21943. This article has 229 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.21943)

[5. (EMMANUEL2018Mutant) NATASHA EMMANUEL, KRISTOPHER A. LOFGREN, ESTHER A. PETERSON, DAVID R. MEIER, ERIC H. JUNG, and PARAIC A. KENNY. Mutant gata3 actively promotes the growth of normal and malignant mammary cells. Anticancer Research, 38(8):4435–4441, July 2018. URL: http://dx.doi.org/10.21873/anticanres.12745, doi:10.21873/anticanres.12745. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.21873/anticanres.12745)

[6. (Fang2018Bcl11b) Difeng Fang, Kairong Cui, Gangqing Hu, Rama Krishna Gurram, Chao Zhong, Andrew J. Oler, Ryoji Yagi, Ming Zhao, Suveena Sharma, Pentao Liu, Bing Sun, Keji Zhao, and Jinfang Zhu. Bcl11b, a novel gata3-interacting protein, suppresses th1 while limiting th2 cell differentiation. Journal of Experimental Medicine, 215(5):1449–1462, March 2018. URL: http://dx.doi.org/10.1084/jem.20171127, doi:10.1084/jem.20171127. This article has 43 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1084/jem.20171127)

[7. (Yang1994Human) Zhuoying Yang, Lin Gu, Paul-Henri Romeo, Dominique Bories, Hozumi Motohashi, Masayuki Yamamoto, and James Douglas Engel. Human gata-3 trans-activation, dna-binding, and nuclear localization activities are organized into distinct structural domains. Molecular and Cellular Biology, 14(3):2201–2212, March 1994. URL: http://dx.doi.org/10.1128/mcb.14.3.2201-2212.1994, doi:10.1128/mcb.14.3.2201-2212.1994. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.3.2201-2212.1994)

[8. (Ho2009GATA3) I-Cheng Ho, Tzong-Shyuan Tai, and Sung-Yun Pai. Gata3 and the t-cell lineage: essential functions before and after t-helper-2-cell differentiation. Nature Reviews Immunology, 9(2):125–135, February 2009. URL: http://dx.doi.org/10.1038/nri2476, doi:10.1038/nri2476. This article has 332 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri2476)

[9. (Afzaljavan2021GATA3) Fahimeh Afzaljavan, Ayeh Sadat Sadr, Sevtap Savas, and Alireza Pasdar. Gata3 somatic mutations are associated with clinicopathological features and expression profile in tcga breast cancer patients. Scientific Reports, January 2021. URL: http://dx.doi.org/10.1038/s41598-020-80680-9, doi:10.1038/s41598-020-80680-9. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-80680-9)

[10. (Kumar2020Structural) Rakesh Kumar, Rahul Kumar, Pranay Tanwar, S. V. S. Deo, Sandeep Mathur, Usha Agarwal, and Showket Hussain. Structural and conformational changes induced by missense variants in the zinc finger domains of gata3 involved in breast cancer. RSC Advances, 10(65):39640–39653, 2020. URL: http://dx.doi.org/10.1039/d0ra07786k, doi:10.1039/d0ra07786k. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/d0ra07786k)

[11. (Lin2017GATA3) M-C Lin, J-J Lin, C-L Hsu, H-F Juan, P-J Lou, and M-C Huang. Gata3 interacts with and stabilizes hif-1α to enhance cancer cell invasiveness. Oncogene, 36(30):4243–4252, March 2017. URL: http://dx.doi.org/10.1038/onc.2017.8, doi:10.1038/onc.2017.8. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2017.8)

[12. (Cohen2014Shift) Helit Cohen, Rotem Ben-Hamo, Moriah Gidoni, Ilana Yitzhaki, Renana Kozol, Alona Zilberberg, and Sol Efroni. Shift in gata3 functions, and gata3 mutations, control progression and clinical presentation in breast cancer. Breast Cancer Research, November 2014. URL: http://dx.doi.org/10.1186/s13058-014-0464-0, doi:10.1186/s13058-014-0464-0. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s13058-014-0464-0)

[13. (Masse2013GATA3) Ingrid Masse, Laetitia Barbollat-Boutrand, Manale El Kharbili, Odile Berthier-Vergnes, Damien Aubert, and Jérôme Lamartine. Gata3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis. Archives of Dermatological Research, 306(2):201–208, December 2013. URL: http://dx.doi.org/10.1007/s00403-013-1435-5, doi:10.1007/s00403-013-1435-5. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00403-013-1435-5)